Clinical Trial Update: Does Sildenafil Improve Endothelial Dysfunction in Rheumatoid Arthritis? [Phase 2]

View source ↗

Summary

Phase 2 trial investigating whether sildenafil improves endothelial dysfunction in rheumatoid arthritis; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Rheumatoid Arthritis

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Kimberly Liang | Conditions: Arthritis, Rheumatoid, Atherosclerosis | Phase 2 | Status: TERMINATED | Results posted: 2021-08-13